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Dear Editor,
The authors present a case of atypical severe (malignant) Mediterranean spotted fever, with a brief 
review on the subject. Although not previously described in Brazil, the possibility of imported cases, 
especially from Portuguese tourists, is real. This case report highlights the severe form of the disease 
and the possibility of atypical presentation with confounding differential diagnosis. A brief review 
of classical presentation is also done. The authors believe it is a valid paper and a good contribution 
to your Journal of Infectious Diseases. The content of the manuscript represents the views of the 
coauthors, and neither the corresponding author nor the coauthors have submitted duplicate or 
overlapping manuscripts elsewhere.
Best regards,
João Figueira-Coelho
[Braz J Infect Dis 2010;14(3):213-216]©Elsevier Editora Ltda.
INTRODUCTION
Mediterranean spotted fever is an endemic zoo-
nosis in the Mediterranean area (Southern Eu-
rope and Northern Africa) caused by Rickettsia 
conorii, an intracellular gram-negative bacteria. 
The main vector for the disease is the dog tick 
Rhipicephalus sanguineus, which occurs mainly 
in the summer months, with 87% of cases be-
tween July and September.1,2 Due to the affi nity 
to endothelial cells, Ricketsia conorii infection 
causes a small to medium vessel vasculitis, lead-
ing to disease clinical manifestations.3 After an 
average incubation period of 6 days, fever and 
ﬂ u-like symptoms are followed, usually within 
3 to 5 days, by a maculopapular rash with ten-
dency to generalization, involving palms and 
plants.4,5 An inoculation scar (“tache noire”) is 
usually identifi ed but Portuguese data report a 
12-61% possibility of not fi nding it.1,6,7,8 Treat-
ment relies mainly on doxycyline 200 mg/day, 
with macrolides josamycine, clarithromycin 
and azithromycin, and the ﬂ uoroquinolone 
ciproﬂ oxacin as possible alternatives;3 the dura-
tion of treatment should be guided by clinical 
response, being usually safe to conclude it 24 h 
after fever ending. Although the early reports 
revealed a low mortality rate of 1-3%,9 since the 
fi rst description of severe cases of the disease 
made by Raoult et al. in 1982,10 its reported 
frequency has increased in many countries. We 
present the case of a 48-year-old women with 
an atypical severe form of the disease.
CASE REPORT
A 48-year-old caucasian women came to the 
Emergency Room with a ten-day history of 
fever (38.5-39.5° C), fronto-occipital head-
aches and polyarthralgia, associated with 
odinophagia, nausea, vomiting, generalized 
abdominal pain, adinamia and asthenia. Four 
days before the beginning of these symptoms 
she had been harvesting grapes at her home-
town in the Portuguese region of Ribatejo, and 
she reported to have been bitten by a tick in 
the right inguinal region. She denied any other 
recent travelling, ingestion of unpasteurized 
milk/milk-derivative or non-drinkable water, 
and direct contact with animals. The patient 
had a past history of rheumatoid arthritis, 
currently medicated with salazopirine and 
etoricoxib, and a depressive disorder with 
trazodone, bromazepam and propranolol. 
On clinical observation, the patient was pale, 
blood pressure 103/65 mmHg, heart rate 100 
bpm, febrile (38.5° C), normal cardiac and 
pulmonary auscultation, painful abdomen on 
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Table 1. Chronological evolution of laboratory tests
 Day 1 Day 2 Day 5 Day 11 Day 26
     (day 8 post discharge)
Leukocytes
(4-10 x 109/L) 3.9 12.1 6.8 5.5 9.3  
Neutrophils
(37-72%) 88.2 78.5 50.7 60.8 65.6
Hemoglobin
(12-16 g/dL) 11.8 10.9 10.3 9.1 10.9
Platelets
(150-400 x 109/L) 56 23 91 503 353
aPTT*
(26-36 sec) 40.9 40.6 26.9 - - 
CRP*
(< 1 mg/dL) 26.1 27.2 9.81 5.6 1  
Urea
(15-45 mg/dL) 49.1 47.8 - 10 19  
Creatinine
(0.7-1.2 mg/dL) 2.4 1.8 1.2 0.7 0.9  
Na+
(137-145 mEq/L) 131 143 150 134 137  
AST*
(14-36 U/L) 165 297 219 33 30  
ALT*
(9-52 U/L) 107 153 151 42 27  
AP*
(38-126 U/L) - 205 310 272 131  
GGT*
(12-43 U/L) - 9-2 106 112 45  
TB*
(0.2-1.3 mg/dL) - 2.7 1.4 0.6 0.3  
DB*
(0-0.3 mg/dL) - 2.3 1.2 0.4 -  
LDH*
(313-618 U/L) 1209 1336 1156 697 417  
CK*
(30-135 U/L) 46 103 117 - -  
Glycemia
(65-105 mg/dL) 118 94 85 - -  
Urynalysis Leucocytes 75  Erythrocytes 2+ Erythrocytes 1+ - -
 Erythrocytes 2+
* aPTT – activated thromboplastin time; AST – aspartate aminotransferase; ALT – alanine aminotransferase; AP – alkaline phos-
phatase; CRP - C - Reactive Protein, GGT – gama glutamyl transferase; TB – total bilirrubin; DB – direct bilirrubin; LDH – lactate 
dehydrogenase; CK – creatinine kinase.
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the epigastric region without hepatomegaly or splenom-
egaly, no lymphadenopathy, no edemas, no articular 
inflammatory signs, and a normal neurologic examina-
tion, including absence of meningitis signs. On the right 
inguinal region, an evanescent 3 cm purple macula was 
identified. 
Laboratory work-up results were as seen on Table 1. 
Chest X-ray showed an interstitial infiltrate and enlarge-
ment of the cardiac area. The diagnosis of Mediterranean 
spotted fever was, thus, assumed and the patient was ad-
mitted in the Infectious Diseases Department and began 
doxicycline 100 mg 12/12h PO. On day 2, the patient pre-
sented mental confusion and disorientation, high fever 
(39º C), tachypnea, hemodynamic instability (blood pres-
sure 86/40 mmHg, heart rate 114 bpm), conjuctival injec-
tion. Due to urinary retention, the patient was undergone 
to catheterization, revealing a yellowish and fetid vaginal 
discharge. The presence of meningitis signs led to a lum-
bar puncture, which revealed no pleocytosis and a nor-
mal protein count. A discrete macular erythematous rash, 
progressing to a petechial aspect, was visible on trunk and 
arms, without involvement of palms and plants, and an 
atypical minimal papular lesion was identified on the left 
shoulder. A laboratory evaluation revealed leukocytosis 
with neutrofilia, and aggravation of liver enzymes (Table 
1). Arterial blood gas revealed respiratory alkalemia (pH 
7.64, pCO
2
 21, pO
2
 79, HCO
3
- 19.2). Chest X-ray showed 
bilateral pleural effusion, mainly on the right side, with-
out adenomegaly or pulmonary parenquimal lesions 
(supported on CT scan). Head CT-scan, abdominal and 
renal ultrasound and echocardiogram were normal. With 
the hypothesis of sepsis of unknown origin, possibly a 
staphylococcal toxic syndrome (although the patient de-
nied the use of vaginal tampons or presence of an intrau-
terine contraceptive device), ceftriaxone 2 gm IV q24 and 
vancomycin 1 gm IV q12 were added to doxicycline. Blood 
cultures were negative as well as the vaginal exsudate cul-
ture. PCR for Chlamydia trachomatis and Neisseria gonor-
rhoeae was negative. Serologic evaluation was negative for 
HIV 1 and 2. Biopsy of the papular lesion revealed a dense 
inﬂ ammatory infi ltrate, composed by histiocytes, lym-
phocytes and neutrophils, with diffuse and perivascular 
distribution, without the typical vasculitic signs present in 
a “tache noire” (Figure 1). Identifi cation of the species was 
not possible due to technical diffi culties in the processing 
of skin tissue samples. The clinical course of the patient was 
positive, despite a diffi cult effervescence period (Figure 2), 
and discharge was possible on day 18, fully recovered. The 
levels of erythrocyte glucose-6-phosphate-dehydrogenase 
(G6PD) were normal - 369 U/1012 erythrocytes (normal 
reference range = 146-376 U/1012 erythrocytes).
The serology for Rickettsia conorii was positive, with 
IgM > 256 and IgG > 1024. 
Figure 1: Biopsy of the inoculation scar.
Figure 2: Temperature graphic.
Figueira-Coelho, Martins, Machado et al.
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DISCUSSION
Mediterranean spotted fever was fi rst described by Conor 
and Bruch in Tunisia in 1910.11 In Portugal, the fi rst de-
scription of this exanthematic disease was made by Delfi m 
Pinheiro in 1923,6 but it was the work of Ricardo Jorge, re-
viewing several cases in 1930, that brought this disease into 
attention, naming it “febre escaro-nodular”.12 In 1982, Raoult 
et al. described the fi rst severe cases (malignant form) of this 
apparent benign disease. This form results from a diffuse 
vasculitic process, involving several organs – kidney, lung, 
liver, pancreas, heart, spleen, skin, brain – eventually leading 
to multiorgan failure. Identifi ed risk factors are: advanced 
age, immunosuppression, diabetes, cardiac insuffi ciency, 
chronic alcoholism, respiratory insuffi ciency, G6PD defi -
ciency, delay in treatment and inadequate antibiotic thera-
py.3 The incidence of severe cases varies according to time. 
In Salamanca, Spain, the disease was more severe in 1983, 
with an incidence of complications of 19%, in contrast to 
3.7% in 1981 and 4.3% in 1982.13 Severity also seems to vary 
according to geographical region. In Beja, a southern dis-
trict of Portugal, during 1997, the mortality of hospitalized 
cases with Mediterranean spotted fever was 32.3%, while in 
Bragança, a northern district, the mortality rate was almost 
nil, despite having the highest incidence of cases in that 
country.14 Of further interest is the fact that, in Portugal, 
cases caused by the strain “Israeli tick typhus” were also 
fi rst described in 1997. A study by de Sousa et al., published 
in 2008, with 140 patients admitted in 13 Portuguese hos-
pitals from 1994 to 2006 with documented identifi cation 
of the ricketsial strain causing the infection, revealed that 
this strain appears to be more virulent than the other strain 
described in the country: the Malish strain.7 In the same 
study, case fatalities were statistically more frequently as-
sociated with symptoms of abdominal pain, nausea, vom-
iting, diarrhea, prostration, altered mental status, evidence 
of tachypnea, hepatomegaly and a petechial rash, labora-
tory fi ndings of leukocytosis (> 11300 cells/mm3, partial 
thromboplastin time > 35 s, glucose level > 110 mg/dL, urea 
level > 50 mg/dL, creatinine level > 1.2 mg/dL, sodium 
< 145 mEq/ L, total bilirrubin level > 1.2 mg/dL, and el-
evated levels of gama-glutamyl transferase, alkaline phos-
phatase and creatine kinase. Alcoholism was the only clas-
sical co-morbidity associated with increased fatality rate.
Our patient had an atypical presentation in several as-
pects: the late occurrence of the rash without involvement 
of palms and plants, the doubtful presence of two inocula-
tion scars, the absence of classic vasculitic fi ndings in the 
histological examination of the inoculation scar, the ex-
tended decline of fever (18 days of treatment). The presence 
of abdominal pain, nausea, vomiting, prostration, altered 
mental status, tachypnea, a petechial rash, elevated partial 
thromboplastin time, hyponatremia, elevated glucose, urea, 
creatinine, total bilirrubin, gama-glutamyl transferase, and 
alkaline phosphatase levels predicted a fatal outcome. Al-
though identifi cation was not possible, the “Israeli tick ty-
phus” strain might have been the responsible strain. Apart 
from the delay in beginning antibiotic treatment, the patient 
had no identifi able classic risk factor, which probably ex-
plains the successful outcome.
CONCLUSION
Severe cases of Mediterranean spotted fever can present with 
atypical signs. The eventual patient instability can lead to 
the consideration of a different diagnosis, usually of infec-
tious origin, until the confi rmation is done by serology. 
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